Thornburg Investment Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Thornburg Investment Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-121,656	Closed	-$13.8M	–	210
2022 Q4	$13.8M	Sell	121,656 -123,156	-50%	-$10.2M	0.23%	71
2022 Q3	$15.2M	Buy	244,812 +127,277	+108%	+$8.89M	0.27%	68
2022 Q2	$9.38M	Sell	117,535 -27,675	-19%	-$2.62M	0.14%	115
2022 Q1	$15.3M	Sell	145,210 -3,324	-2%	-$324K	0.2%	93
2021 Q4	$16M	Sell	148,534 -37,482	-20%	-$4.09M	0.19%	97
2021 Q3	$20.4M	Sell	186,016 -296,240	-61%	-$30.8M	0.25%	78
2021 Q2	$45.2M	Sell	482,256 -15,578	-3%	-$1.43M	0.52%	47
2021 Q1	$45.8M	Sell	497,834 -33,261	-6%	-$2.81M	0.53%	47
2020 Q4	$38.9M	Buy	+531,095	New	+$39.5M	0.46%	51

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Thornburg Investment Management's HZNP Position: Q1 2023 in Review

Thornburg Investment Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 121,656 shares — an estimated $13.8M sold.

Thornburg Investment Management first reported a position in HZNP in Q4 2020 and held it in 9 quarters. The position peaked at $45.8M in Q1 2021. 552 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Thornburg Investment Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Thornburg Investment Management sold 121,656 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $13.8M.
Thornburg Investment Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2020 and held it in 9 quarters.
Thornburg Investment Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $45.8M in Q1 2021.
552 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Thornburg Investment Management's 13F filing for Q1 2023, filed 9 May 2023.